RESEARCH TRIANGLE PARK, NC – A new report shows that oncology drugs spend an average of $76.8 million on marketing from the pre-clinical period to just after launch.

Published by Cutting Edge Information, “Oncology Brand Commercialization: Resource Allocation,” identifies 28 critical variables for the marketing of cancer drugs. The report breaks down marketing spending and staff levels for each of these variables, which include drug class, market entrance, indications, clinical profile, and other factors that impact a brand’s position.

Combining the report’s different sub-categories allows readers to build customized resource profiles. Brands that launch from weak competitive positions, for example, tend to spend more on promotion and outreach than any other group. With average expenditures of $22.3 million on thought leader development and $36.6 million on advertising, these drugs attempt to reach physicians and patients in a bid to win market share.

“We designed this report to let readers look at many different kinds of cancer drugs – then pick relevant data to build budgets and team headcounts that fit their unique situations,” said Eric Bolesh, senior analyst at Cutting Edge Information.

“Oncology Brand Commercialization: Resource Allocation,” available at http://www.PharmaOncologyMarketing.com/, examines oncology commercialization spending and staffing using 28 different commercial variables, such as drug class, market entrance, peak sales projections and approved indications.

Marketing executives use “Oncology Brand Commercialization: Resource Allocation” (http://www.PharmaOncologyMarketing.com) to:
• Win additional budget and staffing resources
• Identify critical patterns in resource allocation from the pre-clinical through post-launch periods
• Compare spending and staffing levels to other brands using several key variables
• Match budgets and team size to specific marketing challenges
• Adjust strategic planning to accommodate your unique commercial position

To download a free summary of this 287-page report, please visit http://www.PharmaOncologyMarketing.com/. For more information on this report or to learn about other Cutting Edge Information research, contact Eric Bolesh at eric_bolesh@cuttingedgeinfo.com or 919-403-6583.

 
<-- Back to the News Page

<-- Back to the Cutting Edge Information home page